ALPS Advisors’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-14,810
| Closed | -$796K | – | 1065 |
|
|
2022
Q3 | $796K | Sell |
14,810
-1,231
| -8% | -$66.2K | 0.01% | 512 |
|
|
2022
Q2 | $893K | Sell |
16,041
-11,729
| -42% | -$653K | 0.01% | 498 |
|
|
2022
Q1 | $1.95M | Sell |
27,770
-3,232
| -10% | -$227K | 0.02% | 214 |
|
|
2021
Q4 | $2.99M | Sell |
31,002
-1,754
| -5% | -$169K | 0.03% | 196 |
|
|
2021
Q3 | $2.85M | Sell |
32,756
-2,228
| -6% | -$194K | 0.03% | 226 |
|
|
2021
Q2 | $2.86M | Sell |
34,984
-11,639
| -25% | -$953K | 0.03% | 225 |
|
|
2021
Q1 | $4.43M | Buy |
46,623
+40
| +0.1% | +$3.8K | 0.04% | 185 |
|
|
2020
Q4 | $2.89M | Buy |
46,583
+13,721
| +42% | +$851K | 0.03% | 220 |
|
|
2020
Q3 | $1.95M | Sell |
32,862
-2,240
| -6% | -$133K | 0.03% | 239 |
|
|
2020
Q2 | $2.45M | Sell |
35,102
-13,006
| -27% | -$907K | 0.03% | 217 |
|
|
2020
Q1 | $2.18M | Sell |
48,108
-8,561
| -15% | -$388K | 0.03% | 206 |
|
|
2019
Q4 | $3.69M | Sell |
56,669
-4,130
| -7% | -$269K | 0.03% | 180 |
|
|
2019
Q3 | $3.78M | Sell |
60,799
-10,105
| -14% | -$627K | 0.03% | 169 |
|
|
2019
Q2 | $5.05M | Sell |
70,904
-13,954
| -16% | -$994K | 0.04% | 155 |
|
|
2019
Q1 | $6.66M | Buy |
84,858
+3,350
| +4% | +$263K | 0.05% | 143 |
|
|
2018
Q4 | $6.9M | Buy |
81,508
+18,741
| +30% | +$1.59M | 0.05% | 135 |
|
|
2018
Q3 | $10.7M | Buy |
62,767
+13,420
| +27% | +$2.3M | 0.07% | 119 |
|
|
2018
Q2 | $6.38M | Buy |
49,347
+3,974
| +9% | +$514K | 0.04% | 149 |
|
|
2018
Q1 | $4.68M | Buy |
45,373
+7,885
| +21% | +$812K | 0.04% | 153 |
|
|
2017
Q4 | $3.2M | Buy |
37,488
+4,461
| +14% | +$381K | 0.02% | 161 |
|
|
2017
Q3 | $2.81M | Buy |
33,027
+2,758
| +9% | +$234K | 0.02% | 169 |
|
|
2017
Q2 | $2.29M | Buy |
30,269
+1,510
| +5% | +$114K | 0.02% | 175 |
|
|
2017
Q1 | $1.9M | Sell |
28,759
-3,436
| -11% | -$227K | 0.01% | 181 |
|
|
2016
Q4 | $2.04M | Sell |
32,195
-10,422
| -24% | -$661K | 0.02% | 178 |
|
|
2016
Q3 | $2.71M | Sell |
42,617
-10,795
| -20% | -$687K | 0.02% | 167 |
|
|
2016
Q2 | $3.97M | Buy |
53,412
+10,492
| +24% | +$781K | 0.04% | 135 |
|
|
2016
Q1 | $2.87M | Sell |
42,920
-7,244
| -14% | -$484K | 0.03% | 136 |
|
|
2015
Q4 | $3.39M | Sell |
50,164
-7,900
| -14% | -$534K | 0.03% | 145 |
|
|
2015
Q3 | $31K | Buy |
58,064
+15,342
| +36% | +$8.2K | 0.03% | 139 |
|
|
2015
Q2 | $2.69M | Buy |
42,722
+15,747
| +58% | +$991K | 0.02% | 147 |
|
|
2015
Q1 | $1.3M | Buy |
+26,975
| New | +$1.3M | 0.01% | 172 |
|
|
2014
Q1 | – | Sell |
-16,822
| Closed | -$650K | – | 642 |
|
|
2013
Q4 | $650K | Buy |
16,822
+8,191
| +95% | +$316K | 0.01% | 170 |
|
|
2013
Q3 | $233K | Buy |
+8,631
| New | +$233K | ﹤0.01% | 583 |
|